Vascular superoxide production by endothelin-1 requires Src non-receptor protein tyrosine kinase and MAPK activation

Atherosclerosis

Volumn 212, Issue 1, 2010, Pages 78-85

  Romero, Miguel ^a   Jiménez, Rosario ^a   Sánchez, Manuel ^a   López Sepúlveda, Rocío ^a   Zarzuelo, Antonio ^a,b   Tamargo, Juan ^c   Pérez Vizcaíno, Francisco ^c,d   Duarte, Juan ^a  

^a UNIVERSITY OF GRANADA   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^d INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Aortic rings; C Src; Endothelin 1; MAPKs; NADPH oxidase

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 4 AMINO 7 TERT BUTYL 5 (4 CHLOROPHENYL)PYRAZOLO[3,4 D]PYRIMIDINE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; CORTACTIN; ENDOTHELIN 1; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN P47; PROTEIN TYROSINE KINASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE OVEREXPRESSION; MALE; NONHUMAN; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; UPREGULATION;

ANIMALS; AORTA, THORACIC; CORTACTIN; ENDOTHELIN-1; ENZYME ACTIVATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; MALE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; NADPH OXIDASE; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; PROTEIN-TYROSINE KINASES; RATS; RATS, WISTAR; SIGNAL TRANSDUCTION; SUPEROXIDES; TIME FACTORS;

EID: 77956228328     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2010.04.031     Document Type: Article

References (30)

1. Miyauchi T., Masaki T. Pathophysiology of endothelin in the cardiovascular system. Annu Rev Physiol 1999, 61:391-415.
2. Li L., Fink G.D., Watts S.W., et al. Endothelin-1 increases vascular superoxide via endothelin(A)-NADPH oxidase pathway in low-renin hypertension. Circulation 2003, 107:1053-1058.
3. Loomis E.D., Sullivan J.C., Osmond D.A., Pollock D.M., Pollock J.S. Endothelin mediates superoxide production and vasoconstriction through activation of NADPH oxidase and uncoupled nitric-oxide synthase in the rat aorta. J Pharmacol Exp Ther 2005, 315:1058-1064.
4. Romero M., Jiménez R., Sánchez M., et al. Quercetin inhibits vascular superoxide production induced by endothelin-1: role of NADPH oxidase, uncoupled eNOS and PKC. Atherosclerosis 2009, 202:58-67.
5. Munzel T., Daiber A., Ullrich V., Mulsch A. Vascular consequences of endothelial nitric oxide synthase uncoupling for the activity and expression of the soluble guanylyl cyclase and the cGMP-dependent protein kinase. Arterioscler Thromb Vasc Biol 2005, 25:1551-1557.
6. Martin G.S. The hunting of the Src. Nat Rev Mol Cell Biol 2001, 2:467-475.
7. Oda Y., Renaux B., Bjorge J., Saifeddine M., Fujita D.J., Hollenberg M.D. c-Src is a major cytosolic tyrosine kinase in vascular tissue. Can J Physiol Pharmacol 1999, 77:606-617.
8. Kodama H., Fukuda K., Takahashi T., et al. Role of EGF Receptor and Pyk2 in endothelin-1-induced ERK activation in rat cardiomyocytes. J Mol Cell Cardiol 2002, 34:139-150.
9. Kodama H., Fukuda K., Takahashi E., et al. Selective involvement of p130Cas/Crk/Pyk2/c-Src in endothelin-1-induced JNK activation. Hypertension 2003, 41:1372-1379.
10. Mishra R., Wang Y., Simonson M.S. Cell cycle signalling by endothelin-1 requires Src nonreceptor protein tyrosine kinase. Mol Pharmacol 2005, 67:2049-2056.
11. Kovacic B., Ilic D., Damsky C.H., Gardner D.G. c-Src activation plays a role in endothelin-dependent hypertrophy of the cardiac myocyte. J Biol Chem 1998, 273:35185-35193.
12. Schieffer B., Drexler H., Ling B.N., Marrero M.B. G protein-coupled receptors control vascular smooth muscle cell proliferation via pp60c-src and p21ras. Am J Physiol 1997, 272:C2019-C2030.
13. Yogi A., Callera G.E., Montezano A.C., et al. Endothelin-1, but not Ang II, activates MAP kinases through c-Src independent Ras-Raf dependent pathways in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2007, 27:1960-1967.
14. Foschi M., Chari S., Dunn M.J., Sorokin A. Biphasic activation of p21ras by endothelin-1 sequentially activates the ERK cascade and phosphatidylinositol 3-kinase. EMBO J 1997, 16:6439-6451.
15. Daou G.B., Srivastava A.K. Reactive oxygen species mediate endothelin-1-induced activation of ERK1/2, PKB, and Pyk2 signalling, as well as protein synthesis, in vascular smooth muscle cells. Free Radic Biol Med 2004, 37:208-215.
16. Pearson G., Robinson F., Beers Gibson T., et al. Mitogen-activated protein kinase pathways: regulation and physiological functions. Endocr Rev 2001, 22:153-183.
17. Ishida M., Ishida T., Thomas S.M., Berk B.C. Activation of extracellular signal-regulated kinases (ERK1/2) by angiotensin II is dependent on c-Src in vascular smooth muscle cells. Circ Res 1998, 82:7-12.
18. Sánchez M., Galisteo M., Vera R., et al. Quercetin downregulates NADPH oxidase, increases eNOS activity and prevents endothelial dysfunction in spontaneously hypertensive rats. J Hypertens 2006, 24:75-84.
19. Stolk J., Rossie W., Dijkman J.H. Apocynin improves the efficacy of secretory leukocyte protease inhibitor in experimental emphysema. Am J Respir Crit Care Med 1994, 150:1628-1631.
20. Ma Y.C., Huang X.Y. Novel regulation and function of Src tyrosine kinase. Cell Mol Life Sci 2002, 59:456-462.
21. Touyz R.M., Yao G., Schiffrin E.L. c-Src induces phosphorylation and translocation of p47phox: role in superoxide generation by angiotensin II in human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2003, 23:981-987.
22. Lyle A.N., Griendling K.K. Modulation of vascular smooth muscle signalling by reactive oxygen species. Physiology 2006, 21:269-280.
23. Makino A., Kamata K. Elevated plasma endothelin-1 level in streptozotocin-induced diabetic rats and responsiveness of the mesenteric arterial bed to endothelin-1. Br J Pharmacol 1998, 123:1065-1072.
24. Takenaka T., Forster H., Epstein M. Protein kinase C and calcium channel activation as determinants of renal vasoconstriction by angiotensin II and endothelin. Circ Res 1993, 73:743-750.
25. Heitzer T., Wenzel U., Hink U., et al. Increased NAD(P)H oxidase-mediated superoxide production in renovascular hypertension: evidence for an involvement of protein kinase C. Kidney Int 1999, 55:252-260.
26. Laplante M.A., Wu R., Moreau P., de Champlain J. Endothelin mediates superoxide production in angiotensin II-induced hypertension in rats. Free Radic Biol Med 2005, 38:589-596.
27. Li L., Chu Y., Fink G.D., Engelhardt J.F., Heistad D.D., Chen A.F. Endothelin-1 stimulates arterial VCAM-1 expression via NADPH oxidase-derived superoxide in mineralocorticoid hypertension. Hypertension 2003, 42:997-1003.
28. Seshiah P.N., Weber D.S., Rocic P., Valppu L., Taniyama Y., Griendling K.K. Angiotensin II stimulation of NAD(P)H oxidase activity: upstream mediators. Circ Res 2002, 91:406-413.
29. Daly R.J. Cortactin signalling and dynamic actin networks. Biochem J 2004, 382:13-25.
30. Touyz R.M., Yao G., Quinn M.T., Pagano P.J., Schiffrin E.L. p47phox associates with the cytoskeleton through cortactin in human vascular smooth muscle cells: role in NAD(P)H oxidase regulation by angiotensin II. Arterioscler Thromb Vasc Biol 2005, 25(3):512-518.